Date posted
Dec
22
In late December 2025, Congress completed action on the FY 2026 National Defense Authorization Act (NDAA)and with it, the...
Read PostFederal Advocacy
Voices Heard in Washington: Federal Advocacy for Bio Community
Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
BioConnections® Jobs
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
Dec
22
Access to capital remains one of the most persistent challenges facing early-stage life sciences companies. On December 11, the U.S. House of...
Read Post
Date posted
Dec
22
Mergers and acquisitions (M&A) are a defining feature of the global life sciences industry. While often discussed in terms of market...
Read Post
Date posted
Dec
22
The U.S. Food and Drug Administration (FDA) has taken a noteworthy step toward modernizing how it collaborates with innovative technology...
Read Post
Date posted
Dec
8
America stands at a pivotal moment in biotechnology and scientific innovation. The National Security Commission on Emerging Biotechnology...
Read Post
Date posted
Dec
8
On December 1, 2025, Washington and London announced an “agreement in principle” that does two big things at once: it shields...
Read Post
Date posted
Dec
8
The Advanced Research Projects Agency for Health (ARPA-H) – Health & Human Service (HHS)’s “high-risk,...
Read Post
Date posted
Dec
8
After the FDA’s Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) authority lapsed at the end of 2024, patient groups and drug...
Read Post
Date posted
Dec
8
A major bipartisan push to overhaul pharmacy benefit managers (PBMs) is back on the Senate agenda. On Dec. 4, Senate Finance Committee...
Read Post
Date posted
Oct
17
On October 9, 2025, the U.S. Senate took a major step toward embedding a retooled BIOSECURE Act into national policy by approving it as an...
Read Post
Date posted
Oct
17
The U.S. Department of Commerce’s decision to launch a Section 232 investigation into imports of medical devices and related equipment has...
Read Post
Date posted
Oct
2
The September 30, 2025, announcement that Pfizer will cut prices on selected drugs (particularly for Medicaid and uninsured populations), tied...
Read Post